K. Pritchard

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

Giuseppe Curigliano, Harold J. Burstein, Eric P. Winer et al. · Annals of Oncology · 2017 · 1.3K citations · Full text

Medicine, Oncology, Breast Oncology +12

Helping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer

Timothy J. Whelan, Carol Sawka, Mark Levine et al. · JNCI Journal of the National Cancer Institute · 2003 · 225 citations

Medicine, Oncology, Breast Oncology +16

Anthracyclines in basal breast cancer: The NCIC-CTG trial MA5 comparing adjuvant CMF to CEF

Maggie C.U. Cheang, Stephen Chia, Dongsheng Tu et al. · Journal of Clinical Oncology · 2009 · 48 citations

Medicine, Oncology, Pharmacology +16

Frequency of vitamin D (Vit D) deficiency at breast cancer (BC) diagnosis and association with risk of distant recurrence and death in a prospective cohort study of T1–3, N0–1, M0 B

Pamela J. Goodwin, Marguerite Ennis, K. Pritchard et al. · Journal of Clinical Oncology · 2008 · 35 citations

Medicine, Endocrinology, Oncology +17

Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study.

Theodore A. Vandenberg, K. Pritchard, E. Eisenhauer et al. · Journal of Clinical Oncology · 1993 · 30 citations

Medicine, Oncology, Pharmacology +17